Maria Lapteva

948 total citations
23 papers, 725 citations indexed

About

Maria Lapteva is a scholar working on Pharmaceutical Science, Dermatology and Immunology. According to data from OpenAlex, Maria Lapteva has authored 23 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 10 papers in Dermatology and 7 papers in Immunology. Recurrent topics in Maria Lapteva's work include Advancements in Transdermal Drug Delivery (16 papers), Dermatology and Skin Diseases (8 papers) and Nail Diseases and Treatments (4 papers). Maria Lapteva is often cited by papers focused on Advancements in Transdermal Drug Delivery (16 papers), Dermatology and Skin Diseases (8 papers) and Nail Diseases and Treatments (4 papers). Maria Lapteva collaborates with scholars based in Switzerland, United States and United Kingdom. Maria Lapteva's co-authors include Yogeshvar N. Kalia, Michael Möller, Robert Gurny, Karine Mondon, Sergio del Río‐Sancho, Taís Gratieri, Ingo Alberti, Niki Karagianni, Maria C. Denis and Ilias Patmanidis and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Nanoscale.

In The Last Decade

Maria Lapteva

23 papers receiving 713 citations

Peers

Maria Lapteva
Maria Lapteva
Citations per year, relative to Maria Lapteva Maria Lapteva (= 1×) peers Boonnada Pamornpathomkul

Countries citing papers authored by Maria Lapteva

Since Specialization
Citations

This map shows the geographic impact of Maria Lapteva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Lapteva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Lapteva more than expected).

Fields of papers citing papers by Maria Lapteva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Lapteva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Lapteva. The network helps show where Maria Lapteva may publish in the future.

Co-authorship network of co-authors of Maria Lapteva

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Lapteva. A scholar is included among the top collaborators of Maria Lapteva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Lapteva. Maria Lapteva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lapteva, Maria, et al.. (2024). Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations. Pharmaceutics. 16(2). 202–202. 8 indexed citations
2.
Cunha‐Filho, Marcílio, et al.. (2023). Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches. International Journal of Pharmaceutics. 648. 123617–123617. 3 indexed citations
3.
Lapteva, Maria, et al.. (2023). Polymeric micelles for cutaneous delivery of the hedgehog pathway inhibitor TAK-441: Formulation development and cutaneous biodistribution in porcine and human skin. International Journal of Pharmaceutics. 644. 123349–123349. 6 indexed citations
5.
Lapteva, Maria, et al.. (2023). Finite sample corrections for average equivalence testing. Statistics in Medicine. 43(5). 833–854. 1 indexed citations
6.
Lapteva, Maria, et al.. (2023). Development of an ex vivo porcine skin model for the preclinical evaluation of subcutaneously injected biomacromolecules. International Journal of Pharmaceutics. 648. 123562–123562. 1 indexed citations
7.
Lapteva, Maria, et al.. (2022). Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression. Pharmaceutics. 14(1). 151–151. 5 indexed citations
8.
Lapteva, Maria, et al.. (2021). Polymeric micelle formulations for the cutaneous delivery of sirolimus: A new approach for the treatment of facial angiofibromas in tuberous sclerosis complex. International Journal of Pharmaceutics. 604. 120736–120736. 18 indexed citations
9.
Rao, Wei, et al.. (2021). DESI-MS imaging to visualize spatial distribution of xenobiotics and endogenous lipids in the skin. International Journal of Pharmaceutics. 607. 120967–120967. 17 indexed citations
10.
Río‐Sancho, Sergio del, Maria Lapteva, Kiran Sonaje, et al.. (2020). Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation. International Journal of Pharmaceutics. 580. 119234–119234. 22 indexed citations
11.
Lapteva, Maria, Marwa A. Sallam, Alexandre Goyon, et al.. (2020). Non-invasive targeted iontophoretic delivery of cetuximab to skin. Expert Opinion on Drug Delivery. 17(4). 589–602. 19 indexed citations
12.
Lapteva, Maria, et al.. (2019). Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod. European Journal of Pharmaceutics and Biopharmaceutics. 142. 553–562. 42 indexed citations
13.
Río‐Sancho, Sergio del, et al.. (2019). Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis. International Journal of Pharmaceutics. 569. 118610–118610. 9 indexed citations
14.
Lapteva, Maria, et al.. (2019). Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966. Scientific Reports. 9(1). 1030–1030. 22 indexed citations
15.
Río‐Sancho, Sergio del, et al.. (2017). Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs. International Journal of Pharmaceutics. 525(1). 43–53. 19 indexed citations
16.
Kranidioti, Ksanthi, Niki Karagianni, Maria C. Denis, et al.. (2016). Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. Journal of Controlled Release. 242. 16–24. 68 indexed citations
17.
Lapteva, Maria, Michael Möller, Robert Gurny, & Yogeshvar N. Kalia. (2015). Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle. Nanoscale. 7(44). 18651–18662. 62 indexed citations
18.
Lapteva, Maria, Karine Mondon, Ilias Patmanidis, et al.. (2014). Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. Journal of Controlled Release. 196. 9–18. 64 indexed citations
19.
Gratieri, Taís, Ingo Alberti, Maria Lapteva, & Yogeshvar N. Kalia. (2013). Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin. European Journal of Pharmaceutical Sciences. 50(5). 609–622. 92 indexed citations
20.
Lapteva, Maria & Yogeshvar N. Kalia. (2013). Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery. Expert Opinion on Drug Delivery. 10(8). 1043–1059. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026